On criteria for evaluating models of absolute risk

Biostatistics

Volumn 6, Issue 2, 2005, Pages 227-239

  Gail, Mitchell H ^a   Pfeiffer, Ruth M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Absolute risk model; Accuracy; Loss functions for clinical decisions; Negative predictive value; Positive predictive value; ROC curve

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; COLON TUMOR; COLONOSCOPY; DECISION MAKING; FEMALE; HUMAN; MIDDLE AGED; RISK; STANDARD; STATISTICAL MODEL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COLONIC NEOPLASMS; COLONOSCOPY; DECISION MAKING; FEMALE; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; RISK; TAMOXIFEN;

EID: 22144490275     PISSN: 14654644     EISSN: None     Source Type: Journal    
DOI: 10.1093/biostatistics/kxi005     Document Type: Article

References (28)

1. ANDERSON, S. J., AHNN, S. AND DUFF, K. (1992). NSABP Breast Cancer Prevention Trial Risk. Assessment Program, Version 2. Pittsburgh, PA: Department of Biostatistics, University of Pittsburgh.
2. BAKER, S. G. (2000). Identifying combinations of cancer markers for further study as triggers of early intervention. Biometrics 56, 1082-1087.
3. BRIER, G. W. (1950). Verification of forecasts expressed in terms of probability. Monthly Weather Review 75, 1-3.
4. COSTANTINO, J. P., GAIL, M. H., PEE, D., ANDERSON, S., REDMOND, C. K., BENICHOU, J. AND WIEAND, H. S. (1999). Validation studies for models projecting the risk of invasive and total breast cancer incidence. Journal of the National Cancer Institute 91, 1541-1548.
5. DAGUM, C. (1985). Lorenz curve. In Kotz, S. and Johnson, N. L. (eds), Encyclopedia of Statistical Sciences, Volume 5. New York: Wiley, pp. 156-161.
6. DODD, L. E. AND PEPE, M. S. (2003). Partial AUC estimation and regression. Biometrics 59, 614-623.
7. EFRON, B. (1978). Regression and ANOVA with zero-one data: measures of residual variation. Journal of the American Statistical Association 73, 113-121.
8. FISHER, B., COSTANTINO, J. P., WICKERHAM, D. L., REDMOND, C. K., KAVANAH, M., CRONIN, W. M., VOGEL, V., ROBIDOUX, A., DIMITROV, N., ATKINS, J., DALY, M., WIEAND, S., TAN-CHIU, E., FORD, L. AND WOLMARK, N. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90, 1371-1388.
9. FREEDMAN, A. N., GRAUBARD, B. I., RAO, S. R., MCCASKELL-STEVENS, W., BALLARD-BARBASH, R. AND GAIL, M. H. (2003). Estimates of the number of U.S. women who could benefit from tamoxifen for breast cancer chemoprevention. Journal of the National Cancer Institute 95, 526-532.
10. GAIL, M. H., BRINTON, L. A., BYAR, D. P., CORLE, D. K., GREEN, S. B., SCHAIRER, C. AND MULVIHILL, J. J. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute 81, 1879-1886.
11. GAIL, M. H., COSTANTINO, J. P., BRYANT, J., CROYLE, R., FREEDMAN, L., HELZLSOUER, K. AND VOGEL, V. (1999). Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. Journal of the National Cancer Institute 91, 1829-1846.
12. GILULA, Z. AND HABERMAN, S. J. (1995). Dispersion of categorical variables and penalty functions: derivation, estimation, and comparability. Journal of the American Statistical Association 90, 1447-1452.
13. HABERMAN, S. J. (1982). Analysis of dispersion of multinomial responses. Journal of the American Statistical Association 77, 568-580.
14. HAND, D. J. (1981). Discrimination and Classification. Chichester: John Wiley.
15. HAND, D. J. (1997). Construction and Assessment of Classification Rules. Chichester: John Wiley.
16. HAND, D. J. (2001). Measuring diagnostic accuracy and statistical prediction rules. Statistica Neerlandia 55, 3-16.
17. KORN, E. L. AND SIMON, R. (1991). Explained residual variation, explained risk, and goodness of fit. American Statistician 45, 201-206.
18. LEMESHOW, S. AND HOSMER, JR, D. W. (1982). A review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology 115, 92-106.
19. LIAO, J. G. AND MCGEE, D. (2003). Adjusted coefficients of determination for logistic regression. The American Statistician 57, 161-165.
20. MALDONADO, G. AND GREENLAND, S. (2002). Estimating causal effects. International Journal of Epidemiology 31, 422-429.
21. MCLACHLAN, G. J. (1992). Discrimination Analysis and Statistical Pattern Recognition. New York: John Wiley.
22. PEPE, M. S. (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford: Oxford University Press.
23. PEPE, M.S., JANES, H., LONGTON, G., LEISENRING, W. AND NEWCOMB, P. (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American Journal of Epidemiology 159, 882-890.
24. PHAROAH, P. D., ANTONIOU, A., BOBROW, M., ZIMMERN, R. L., EASTON, D. F. AND PONDER, B. A. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nature Genetics 31, 33-36.
25. ROCKHILL, B., SPIEGELMAN, D., BYRNE, C., HUNTER, D. J. AND COLDITZ, G. A. (2001). Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. Journal of the National Cancer Institute 93, 358-366.
26. TSIATIS, A. A. (1998). Competing risks. In Armitage, P. and Colton, T. (eds), Encyclopedia of Biostatistics, Volume I. Chichester: John Wiley, pp. 824-834.
27. WEINSTEIN, M. C., FINEBERG, H. V., ELSTEIN, A. S., FRAZIER, H. S., NEUHAUSER, D., NEUTRA, R. R. AND MCNEIL, B. J. (1980). Clinical Decision Analysis. Philadelphia, PA: W.B. Saunders.
28. WIEAND, S., GAIL, M. H., JAMES, B. R. AND JAMES, K. L. (1989). A family of nonparametric statistics for comparing diagnostic tests with paired or unpaired data. Biometrika 76, 585-592.